[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

EMEA (Europe, Middle East and Africa) Irritable Bowel Syndrome Treatment Market Report 2017

December 2017 | 103 pages | ID: E4BE490C725EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA Irritable Bowel Syndrome Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Irritable Bowel Syndrome Treatment for these regions, from 2012 to 2022 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Irritable Bowel Syndrome Treatment market competition by top manufacturers/players, with Irritable Bowel Syndrome Treatment sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Abbott Laboratories
  • Synergy Pharmaceuticals, Inc.
  • Sucampo Pharmaceuticals, Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Novartis AG
  • GlaxoSmithKline plc.
  • Ironwood Pharmaceuticals, Inc.
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Lubiprostone
  • Linaclotide
  • Eluxadoline
  • Rifaximin
  • Ramosetron Hydrochloride
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Home Care
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) Irritable Bowel Syndrome Treatment Market Report 2017

1 IRRITABLE BOWEL SYNDROME TREATMENT OVERVIEW

1.1 Product Overview and Scope of Irritable Bowel Syndrome Treatment
1.2 Classification of Irritable Bowel Syndrome Treatment
  1.2.1 EMEA Irritable Bowel Syndrome Treatment Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Irritable Bowel Syndrome Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Lubiprostone
  1.2.4 Linaclotide
  1.2.5 Eluxadoline
  1.2.6 Rifaximin
  1.2.7 Ramosetron Hydrochloride
  1.2.8 Others
1.3 EMEA Irritable Bowel Syndrome Treatment Market by Application/End Users
  1.3.1 EMEA Irritable Bowel Syndrome Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home Care
1.4 EMEA Irritable Bowel Syndrome Treatment Market by Region
  1.4.1 EMEA Irritable Bowel Syndrome Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Irritable Bowel Syndrome Treatment (2012-2022)
  1.5.1 EMEA Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2022)

2 EMEA IRRITABLE BOWEL SYNDROME TREATMENT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Irritable Bowel Syndrome Treatment Market Competition by Players/Manufacturers
  2.1.1 EMEA Irritable Bowel Syndrome Treatment Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Irritable Bowel Syndrome Treatment Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Irritable Bowel Syndrome Treatment Sale Price by Players (2012-2017)
2.2 EMEA Irritable Bowel Syndrome Treatment (Volume and Value) by Type/Product Category
  2.2.1 EMEA Irritable Bowel Syndrome Treatment Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Irritable Bowel Syndrome Treatment Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Irritable Bowel Syndrome Treatment Sale Price by Type (2012-2017)
2.3 EMEA Irritable Bowel Syndrome Treatment (Volume) by Application
2.4 EMEA Irritable Bowel Syndrome Treatment (Volume and Value) by Region
  2.4.1 EMEA Irritable Bowel Syndrome Treatment Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Irritable Bowel Syndrome Treatment Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Irritable Bowel Syndrome Treatment Sales Price by Region (2012-2017)

3 EUROPE IRRITABLE BOWEL SYNDROME TREATMENT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Irritable Bowel Syndrome Treatment Sales and Value (2012-2017)
  3.1.1 Europe Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2017)
3.2 Europe Irritable Bowel Syndrome Treatment Sales and Market Share by Type
3.3 Europe Irritable Bowel Syndrome Treatment Sales and Market Share by Application
3.4 Europe Irritable Bowel Syndrome Treatment Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Irritable Bowel Syndrome Treatment Sales Volume by Countries (2012-2017)
  3.4.2 Europe Irritable Bowel Syndrome Treatment Revenue by Countries (2012-2017)
  3.4.3 Germany Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
  3.4.4 France Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
  3.4.5 UK Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
  3.4.6 Russia Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
  3.4.7 Italy Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)

4 MIDDLE EAST IRRITABLE BOWEL SYNDROME TREATMENT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Irritable Bowel Syndrome Treatment Sales and Value (2012-2017)
  4.1.1 Middle East Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2017)
4.2 Middle East Irritable Bowel Syndrome Treatment Sales and Market Share by Type
4.3 Middle East Irritable Bowel Syndrome Treatment Sales and Market Share by Application
4.4 Middle East Irritable Bowel Syndrome Treatment Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Irritable Bowel Syndrome Treatment Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Irritable Bowel Syndrome Treatment Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
  4.4.4 Israel Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
  4.4.5 UAE Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
  4.4.6 Iran Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)

5 AFRICA IRRITABLE BOWEL SYNDROME TREATMENT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Irritable Bowel Syndrome Treatment Sales and Value (2012-2017)
  5.1.1 Africa Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2017)
5.2 Africa Irritable Bowel Syndrome Treatment Sales and Market Share by Type
5.3 Africa Irritable Bowel Syndrome Treatment Sales and Market Share by Application
5.4 Africa Irritable Bowel Syndrome Treatment Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Irritable Bowel Syndrome Treatment Sales Volume by Countries (2012-2017)
  5.4.2 Africa Irritable Bowel Syndrome Treatment Revenue by Countries (2012-2017)
  5.4.3 South Africa Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Irritable Bowel Syndrome Treatment Sales and Growth Rate (2012-2017)

6 EMEA IRRITABLE BOWEL SYNDROME TREATMENT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Abbott Laboratories
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Irritable Bowel Syndrome Treatment Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Synergy Pharmaceuticals, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Irritable Bowel Syndrome Treatment Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sucampo Pharmaceuticals, Inc.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Irritable Bowel Syndrome Treatment Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Valeant Pharmaceuticals International, Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Irritable Bowel Syndrome Treatment Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Ardelyx, Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Irritable Bowel Syndrome Treatment Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Ardelyx, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Astellas Pharma Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Irritable Bowel Syndrome Treatment Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novartis AG
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Irritable Bowel Syndrome Treatment Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis AG Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline plc.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Irritable Bowel Syndrome Treatment Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Ironwood Pharmaceuticals, Inc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Irritable Bowel Syndrome Treatment Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 IRRITABLE BOWEL SYNDROME TREATMENT MANUFACTURING COST ANALYSIS

7.1 Irritable Bowel Syndrome Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Irritable Bowel Syndrome Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Irritable Bowel Syndrome Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Irritable Bowel Syndrome Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA IRRITABLE BOWEL SYNDROME TREATMENT MARKET FORECAST (2017-2022)

11.1 EMEA Irritable Bowel Syndrome Treatment Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Irritable Bowel Syndrome Treatment Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Irritable Bowel Syndrome Treatment Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Irritable Bowel Syndrome Treatment Price and Trend Forecast (2017-2022)
11.2 EMEA Irritable Bowel Syndrome Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Irritable Bowel Syndrome Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Irritable Bowel Syndrome Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Irritable Bowel Syndrome Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Irritable Bowel Syndrome Treatment Sales Forecast by Type (2017-2022)
11.7 EMEA Irritable Bowel Syndrome Treatment Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Irritable Bowel Syndrome Treatment
Figure EMEA Irritable Bowel Syndrome Treatment Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Irritable Bowel Syndrome Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Lubiprostone Product Picture
Figure Linaclotide Product Picture
Figure Eluxadoline Product Picture
Figure Rifaximin Product Picture
Figure Ramosetron Hydrochloride Product Picture
Figure Others Product Picture
Figure EMEA Irritable Bowel Syndrome Treatment Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Irritable Bowel Syndrome Treatment by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Care Examples
Table Key Downstream Customer in Home Care
Figure EMEA Irritable Bowel Syndrome Treatment Market Size (Million USD) by Region (2012-2022)
Figure Europe Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Irritable Bowel Syndrome Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Irritable Bowel Syndrome Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Africa Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Irritable Bowel Syndrome Treatment Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Irritable Bowel Syndrome Treatment Sales Volume and Growth Rate (2012-2022)
Figure EMEA Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Irritable Bowel Syndrome Treatment Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Sales Share by Players (2012-2017)
Figure 2016 Irritable Bowel Syndrome Treatment Sales Share by Players
Figure 2017 Irritable Bowel Syndrome Treatment Sales Share by Players
Figure EMEA Irritable Bowel Syndrome Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Revenue (Million USD) by Players (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Revenue Share by Players (2012-2017)
Table 2016 EMEA Irritable Bowel Syndrome Treatment Revenue Share by Players
Table 2017 EMEA Irritable Bowel Syndrome Treatment Revenue Share by Players
Table EMEA Irritable Bowel Syndrome Treatment Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Sales Share by Type (2012-2017)
Figure Sales Market Share of Irritable Bowel Syndrome Treatment by Type (2012-2017)
Figure EMEA Irritable Bowel Syndrome Treatment Sales Market Share by Type (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Irritable Bowel Syndrome Treatment by Type in 2016
Table EMEA Irritable Bowel Syndrome Treatment Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Sales Share by Application (2012-2017)
Figure Sales Market Share of Irritable Bowel Syndrome Treatment by Application (2012-2017)
Figure EMEA Irritable Bowel Syndrome Treatment Sales Market Share by Application in 2016
Table EMEA Irritable Bowel Syndrome Treatment Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Sales Share by Region (2012-2017)
Figure Sales Market Share of Irritable Bowel Syndrome Treatment by Region (2012-2017)
Figure EMEA Irritable Bowel Syndrome Treatment Sales Market Share in 2016
Table EMEA Irritable Bowel Syndrome Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Irritable Bowel Syndrome Treatment Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Irritable Bowel Syndrome Treatment by Region (2012-2017)
Figure EMEA Irritable Bowel Syndrome Treatment Revenue Market Share Regions in 2016
Table EMEA Irritable Bowel Syndrome Treatment Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2012-2017)
Table Europe Irritable Bowel Syndrome Treatment Sales (K Pcs) by Type (2012-2017)
Table Europe Irritable Bowel Syndrome Treatment Market Share by Type (2012-2017)
Figure Europe Irritable Bowel Syndrome Treatment Market Share by Type in 2016
Table Europe Irritable Bowel Syndrome Treatment Sales (K Pcs) by Application (2012-2017)
Table Europe Irritable Bowel Syndrome Treatment Market Share by Application (2012-2017)
Figure Europe Irritable Bowel Syndrome Treatment Market Share by Application in 2016
Table Europe Irritable Bowel Syndrome Treatment Sales (K Pcs) by Countries (2012-2017)
Table Europe Irritable Bowel Syndrome Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Irritable Bowel Syndrome Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Irritable Bowel Syndrome Treatment Sales Market Share by Countries in 2016
Table Europe Irritable Bowel Syndrome Treatment Revenue (Million USD) by Countries (2012-2017)
Table Europe Irritable Bowel Syndrome Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Irritable Bowel Syndrome Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Irritable Bowel Syndrome Treatment Revenue Market Share by Countries in 2016
Figure Germany Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Irritable Bowel Syndrome Treatment Sales (K Pcs) by Type (2012-2017)
Table Middle East Irritable Bowel Syndrome Treatment Market Share by Type (2012-2017)
Figure Middle East Irritable Bowel Syndrome Treatment Market Share by Type (2012-2017)
Table Middle East Irritable Bowel Syndrome Treatment Sales (K Pcs) by Applications (2012-2017)
Table Middle East Irritable Bowel Syndrome Treatment Market Share by Applications (2012-2017)
Figure Middle East Irritable Bowel Syndrome Treatment Sales Market Share by Application in 2016
Table Middle East Irritable Bowel Syndrome Treatment Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Irritable Bowel Syndrome Treatment Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Irritable Bowel Syndrome Treatment Sales Volume Market Share by Countries in 2016
Table Middle East Irritable Bowel Syndrome Treatment Revenue (Million USD) by Countries (2012-2017)
Table Middle East Irritable Bowel Syndrome Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Irritable Bowel Syndrome Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Irritable Bowel Syndrome Treatment Revenue Market Share by Countries in 2016
Figure Saudi Arabia Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Irritable Bowel Syndrome Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Irritable Bowel Syndrome Treatment Sales (K Pcs) by Type (2012-2017)
Table Africa Irritable Bowel Syndrome Treatment Sales Market Share by Type (2012-2017)
Figure Africa Irritable Bowel Syndrome Treatment Sales Market Share by Type (2012-2017)
Figure Africa Irritable Bowel Syndrome Treatment Sales Market Share by Type in 2016
Table Africa Irritable Bowel Syndrome Treatment Sales (K Pcs) by Application (2012-2017)
Table Africa Irritable Bowel Syndrome Treatment Sales Market Share by Application (2012-2017)
Figure Africa Irritable Bowel Syndrome Treatment Sales Market Share by Application (2012-2017)
Table Africa Irritable Bowel Syndrome Treatment Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Irritable Bowel Syndrome Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Irritable Bowel Syndrome Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Irritable Bowel Syndrome Treatment Sales Market Share by Countries in 2016
Table Africa Irritable Bowel Syndrome Treatment Revenue (Million USD) by Countries (2012-2017)
Table Africa Irritable Bowel Syndrome Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Irritable Bowel Syndrome Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Irritable Bowel Syndrome Treatment Revenue Market Share by Countries in 2016
Figure South Africa Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Table Abbott Laboratories Irritable Bowel Syndrome Treatment Basic Information List
Table Abbott Laboratories Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abbott Laboratories Irritable Bowel Syndrome Treatment Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Irritable Bowel Syndrome Treatment Revenue Market Share in EMEA (2012-2017)
Table Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Basic Information List
Table Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales Market Share in EMEA (2012-2017)
Figure Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Revenue Market Share in EMEA (2012-2017)
Table Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Basic Information List
Table Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales Market Share in EMEA (2012-2017)
Figure Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Revenue Market Share in EMEA (2012-2017)
Table Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Basic Information List
Table Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Sales Market Share in EMEA (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Revenue Market Share in EMEA (2012-2017)
Table Ardelyx, Inc. Irritable Bowel Syndrome Treatment Basic Information List
Table Ardelyx, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ardelyx, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Ardelyx, Inc. Irritable Bowel Syndrome Treatment Sales Market Share in EMEA (2012-2017)
Figure Ardelyx, Inc. Irritable Bowel Syndrome Treatment Revenue Market Share in EMEA (2012-2017)
Table Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Basic Information List
Table Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Sales Market Share in EMEA (2012-2017)
Figure Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Irritable Bowel Syndrome Treatment Basic Information List
Table Novartis AG Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis AG Irritable Bowel Syndrome Treatment Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Irritable Bowel Syndrome Treatment Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Basic Information List
Table GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Revenue Market Share in EMEA (2012-2017)
Table Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Basic Information List
Table Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Sales Market Share in EMEA (2012-2017)
Figure Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Irritable Bowel Syndrome Treatment
Figure Manufacturing Process Analysis of Irritable Bowel Syndrome Treatment
Figure Irritable Bowel Syndrome Treatment Industrial Chain Analysis
Table Raw Materials Sources of Irritable Bowel Syndrome Treatment Major Manufacturers in 2016
Table Major Buyers of Irritable Bowel Syndrome Treatment
Table Distributors/Traders List
Figure EMEA Irritable Bowel Syndrome Treatment Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Irritable Bowel Syndrome Treatment Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Irritable Bowel Syndrome Treatment Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Irritable Bowel Syndrome Treatment Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Irritable Bowel Syndrome Treatment Sales Market Share Forecast by Region (2017-2022)
Table EMEA Irritable Bowel Syndrome Treatment Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Irritable Bowel Syndrome Treatment Revenue Market Share Forecast by Region (2017-2022)
Table Europe Irritable Bowel Syndrome Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Irritable Bowel Syndrome Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Europe Irritable Bowel Syndrome Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Irritable Bowel Syndrome Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Irritable Bowel Syndrome Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Irritable Bowel Syndrome Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Irritable Bowel Syndrome Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Irritable Bowel Syndrome Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Irritable Bowel Syndrome Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Irritable Bowel Syndrome Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Africa Irritable Bowel Syndrome Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Irritable Bowel Syndrome Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Irritable Bowel Syndrome Treatment Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Irritable Bowel Syndrome Treatment Sales Market Share Forecast by Type (2017-2022)
Table EMEA Irritable Bowel Syndrome Treatment Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Irritable Bowel Syndrome Treatment Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications